S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.46%)
BABA   86.74 (+1.40%)
AMD   102.82 (+0.06%)
T   15.02 (+0.07%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.79%)
GE   110.55 (-1.59%)
DIS   81.05 (+1.15%)
AMC   7.99 (+2.57%)
PFE   33.17 (+3.37%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
LON:CRV

Craven House Capital (CRV) Share Forecast, Price & News

GBX 0.14
0.00 (0.00%)
(As of 09/28/2023 09:00 PM ET)
Compare
Today's Range
0.15
0.15
50-Day Range
0.14
0.17
52-Week Range
0.06
0.45
Volume
N/A
Average Volume
6,598 shs
Market Capitalization
£5,597.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CRV stock logo

About Craven House Capital (LON:CRV) Stock

Craven House Capital Plc operates as an investment company. It primarily focuses on investing in or acquiring a portfolio of companies, partnerships, joint ventures, businesses, or other assets participating in the e-commerce sector. The company was formerly known as AIM Investments plc and changed its name to Craven House Capital Plc in August 2011. Craven House Capital Plc was incorporated in 2004 and is based in London, the United Kingdom.

CRV Price History

CRV Stock News Headlines

Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's
A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>
CRV/USD - Curve DAO Token US Dollar
Craven House Capital PLC
Craven House Capital Regulatory News
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's
A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>
Craven House Capital FY 2021 Loss Narrowed
Craven House Capital Share Chat
See More Headlines
Receive CRV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Craven House Capital and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£-1,657,000.00
Cash Flow
GBX 0.10 per share
Book Value
GBX 133 per share

Miscellaneous

Free Float
N/A
Market Cap
£5,597.00
Optionable
Not Optionable
Beta
0.28
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Brian Winters
    Gen. Counsel
  • Ms. Tamra Spink
    Company Sec.













CRV Stock - Frequently Asked Questions

How have CRV shares performed in 2023?

Craven House Capital's stock was trading at GBX 0.09 at the beginning of the year. Since then, CRV stock has increased by 70.6% and is now trading at GBX 0.15.
View the best growth stocks for 2023 here
.

What is Craven House Capital's stock symbol?

Craven House Capital trades on the London Stock Exchange (LON) under the ticker symbol "CRV."

How do I buy shares of Craven House Capital?

Shares of CRV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Craven House Capital's stock price today?

One share of CRV stock can currently be purchased for approximately GBX 0.15.

How much money does Craven House Capital make?

Craven House Capital (LON:CRV) has a market capitalization of £5,597.00 and generates £-1,657,000.00 in revenue each year.

How can I contact Craven House Capital?

Craven House Capital's mailing address is International House, 776-778 Barking Road, London E13 9PJ, United Kingdom. The official website for the company is www.cravenhousecapital.com. The company can be reached via phone at 44 2032 868130.

This page (LON:CRV) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -